Development Pipeline

Drugs Being Developed

For Clinical Trials

Jabez Applications

In seeking new and improved pharmaceutical products, we have currently identified and begun development on 15 new drug products in our development pipeline. These products are on prescription, OTC and nutraceutical commercial pathways.

Pharmaceuticals for Clinical Trials

50/50™ Branded CBD Analgesic Combinations

Jabez Wellness Nutraceutical Products

Jabez Currently Has 15 Products in the Development Pipeline

Pharmaceuticals for Clinical Trials

  • Clinical Trial and Management of a CBD medication for the indication of Stress/Anxiety
  • Clinical Trial and Management of a CBD drug and or hybrid CBD/THC drug for debilitating side effects of highly toxic Oncology drugs
  • Clinical Trial and Management of a CBD drug and or hybrid CBD/THC drug for Concussions and CTE
  • Clinical Trial and Management of a CBD drug and or hybrid CBD/THC drug for Antispasmodics

50/50™ Branded CBD Analgesic Combinations

  • Regulatory pathway determination and CTM for Naproxen and CBD
  • Regulatory pathway determination and CTM for Aspirin and CBD
  • Regulatory pathway determination and CTM for Acetaminophen and CBD
  • Regulatory pathway determination and CTM for Ibuprofen and CBD

Jabez Wellness Nutraceutical Products

  • Science-backed dosage form development for Melatonin and CBD for Sleep
  • Science-backed dosage form development for Chondroitin, Glucosamine and CBD for Arthritis and Pain
  • Science-backed dosage form development for Lecithin and CBD for Memory
  • Science-backed dosage form development for Omega-3 Fatty Acids and CBD for use in memory building and heart healthy supplement
  • Science-backed dosage form development for Benzocaine and CBD for sunburn and insect bites and mild rashes
  • Science-backed dosage form development for Pramoxine and CBD for itch relief
  • Science-backed dosage form development for PVP Iodine and CBD for minor abrasions and open stinging cuts